Artificial intelligence and real-world data for drug and food safety - A regulatory science perspective.

Journal: Regulatory toxicology and pharmacology : RTP
Published Date:

Abstract

In 2013, the Global Coalition for Regulatory Science Research (GCRSR) was established with members from over ten countries (www.gcrsr.net). One of the main objectives of GCRSR is to facilitate communication among global regulators on the rise of new technologies with regulatory applications through the annual conference Global Summit on Regulatory Science (GSRS). The 11th annual GSRS conference (GSRS21) focused on "Regulatory Sciences for Food/Drug Safety with Real-World Data (RWD) and Artificial Intelligence (AI)." The conference discussed current advancements in both AI and RWD approaches with a specific emphasis on how they impact regulatory sciences and how regulatory agencies across the globe are pursuing the adaptation and oversight of these technologies. There were presentations from Brazil, Canada, India, Italy, Japan, Germany, Switzerland, Singapore, the United Kingdom, and the United States. These presentations highlighted how various agencies are moving forward with these technologies by either improving the agencies' operation and/or preparing regulatory mechanisms to approve the products containing these innovations. To increase the content and discussion, the GSRS21 hosted two debate sessions on the question of "Is Regulatory Science Ready for AI?" and a workshop to showcase the analytical data tools that global regulatory agencies have been using and/or plan to apply to regulatory science. Several key topics were highlighted and discussed during the conference, such as the capabilities of AI and RWD to assist regulatory science policies for drug and food safety, the readiness of AI and data science to provide solutions for regulatory science. Discussions highlighted the need for a constant effort to evaluate emerging technologies for fit-for-purpose regulatory applications. The annual GSRS conferences offer a unique platform to facilitate discussion and collaboration across regulatory agencies, modernizing regulatory approaches, and harmonizing efforts.

Authors

  • Shraddha Thakkar
    a Division of Bioinformatics and Biostatistics , National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson , AR , USA.
  • William Slikker
    National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.
  • Frank Yiannas
    Food and Drug Administration (FDA), USA.
  • Primal Silva
    Canadian Food Inspection Agency (CFIA), Canada.
  • Burton Blais
    Canadian Food Inspection Agency (CFIA), Canada.
  • Kern Rei Chng
    National Centre for Food Science, Singapore Food Agency (SFA), Singapore.
  • Zhichao Liu
    a Division of Bioinformatics and Biostatistics , National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson , AR , USA.
  • Alok Adholeya
    The Energy and Resources Institute (TERI), New Delhi, India.
  • Francesco Pappalardo
    Department of Drug Sciences, University of Catania , Catania, Italy.
  • Mônica da Luz Carvalho Soares
    Brazilian Health Regulatory Agency (ANVISA), Brazil.
  • Patrick E Beeler
    Department of Internal Medicine, University Hospital Zurich and University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Electronic address: patrick.beeler@usz.ch.
  • Maurice Whelan
    Joint Research Center (JRC), Spain.
  • Ruth Roberts
    c ApconiX Ltd , Alderley Edge , UK.
  • Jurgen Borlak
    Hannover Medical School, Germany.
  • Martha Hugas
    European Food Safety Authority (EFSA), Italy.
  • Carlos Torrecilla-Salinas
    Joint Research Center (JRC), Spain.
  • Philippe Girard
    Swiss Agency for Therapeutic Products, Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland.
  • Matthew C Diamond
    Digital Health Center of Excellence, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Didier Verloo
    European Food Safety Authority (EFSA), Italy.
  • Binay Panda
    Ganit Labs, Bio-IT Centre, Institute of Bioinformatics and Applied Biotechnology, Bangalore, 560 100, India; Strand Life Sciences, Bangalore, 560 024, India.
  • Miquella C Rose
    Burroughs Wellcome Fund (BWF), USA.
  • Joaquim Berenguer Jornet
    European Medical Agency (EMA), the Netherlands.
  • Ayako Furuhama
    National Institute of Health Sciences (NIHS), Japan.
  • Hong Fang
    b Office of Scientific Coordination , National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson , AR , USA.
  • Ernest Kwegyir-Afful
    Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Kasey Heintz
    Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Kirk Arvidson
    Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Juan Garcia Burgos
    European Medical Agency (EMA), the Netherlands.
  • Alexander Horst
    Swiss Agency for Therapeutic Products, Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland.
  • Weida Tong
    National Center for Toxicological Research, Division of Bioinformatics and Biostatistics, U.S. Food and Drug Administration, Jefferson, AR, United States.